The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

Gennova Biopharmaceuticals, in partnership with CEPI, will advance the development of a self-amplifying mRNA vaccine against ...

The public issue will be a mix of fresh issuance of equity shares worth Rs 200 crore, and an offer-for-sale of 19.2 lakh shares by existing shareholders including promoters.

Trent has served over 100 million customers across 230 cities through its Westside & Zudio brands, as per a regulatory filing ...

Currently there are no authorized vaccines or targeted drugs against Nipah, which kills an estimated 75% of those it infects.

Gennova Biopharmaceuticals Ltd. on Tuesday announced that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), a subsidiary of Emcure Pharmaceuticals Ltd. for the ...

High construction costs and slow sales are already hampering the growth of the real estate sector in Maharashtra, according ...

Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking ...

Dr Sanjay Singh, CEO of Gennova Biopharmaceuticals, said the firm will do preclinical and phase 1 vaccine tests in India, ...

Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks in South and ...